Treatment of allograft recipients with donor-specific transfusion and anti-CD154 antibody leads to deletion of alloreactive CD8+ T cells and prolonged graft survival in a CTLA4-dependent manner

Journal of Immunology

Volumn 164, Issue 1, 2000, Pages 512-521

  Iwakoshi, Neal N ^a   Mordes, John P ^a   Markees, Thomas G ^a   Phillips, Nancy E ^a   Rossini, Aldo A ^a   Greiner, Dale L ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD40 LIGAND MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY; UNCLASSIFIED DRUG;

ALLOIMMUNITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; GRAFT SURVIVAL; HISTOCOMPATIBILITY; IMMUNOSUPPRESSIVE TREATMENT; KNOCKOUT MOUSE; MALE; MOUSE; NONHUMAN; ORGAN DONOR; PRIORITY JOURNAL; RECIPIENT; SKIN ALLOGRAFT; T LYMPHOCYTE SUBPOPULATION;

EID: 0033980596     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.164.1.512     Document Type: Article

References (66)

1. Rossini, A. A., D. L. Greiner, and J. P. Mordes. 1999. Induction of immunological tolerance for transplantation. Physiol. Rev. 79:99.
2. Clark, L. B., T. M. Foy, and R. J. Noelle. 1996. CD40 and its ligand. Adv. Immunol. 63:43.
3. Foy, T. M., A. Aruffo, J. Bajorath, J. E. Buhlmann, and R. J. Noelle. 1996. Immune regulation by CD40 and its ligand gp39. Annu. Rev. Immunol. 14:591.
4. Noelle, R. J., J. A. Ledbetter, and A. Aruffo. 1992. CD40 and its ligand, an essential ligand-receptor pair for thymus-dependent B-cell activation. Immunol. Today 13:431.
5. Calderhead, D. M., J. E. Buhlmann, A. J. M. Van den Eertwegh, E. Claassen, R. J. Noelle, and H. P. Fell. 1993. Cloning of mouse Ox40: a T cell activation marker that may mediate T-B cell interactions. J. Immunol. 151:5261.
6. + T cells. J. Immunol. 151:2497.
7. Noelle, R. J., M. Roy, D. M. Shepherd, I. Stamenkovic, J. A. Ledbetter, and A. Aruffo. 1992. A 39-kDa protein on activated helper T cells binds CD40 and transduces the signal for cognate activation of B cells. Proc. Natl. Acad. Sci. USA 89:6550.
8. Grewal, I. S., and R. A. Flavell. 1998. CD40 and CD154 in cell-mediated immunity. Annu. Rev. Immunol. 16:111.
9. Niimi, M., T. C. Pearson, C. P. Larsen, D. Z. Alexander, D. Hollenbaugh, A. Aruffo, P. S. Linsley, E. Thomas, K. Campbell, W. C. Fanslow, et al. 1998. The role of the CD40 pathway in alloantigen-induced hyporesponsiveness in vivo. J. Immunol. 161:5331.
10. Rossini, A. A., J. P. Mordes, T. G. Markees, N. E. Phillips, E. J. Gordon, and D. L. Greiner. 1999. Induction of islet transplantation tolerance using donor specific transfusion and anti-CD154 monoclonal antibody. Transplant. Proc. 31:629.
11. Zheng, X. X., T. G. Markees, W. W. Hancock, Y. Li, D. L. Greiner, X. C. Li, J. P. Mordes, M. H. Sayegh, A. A. Rossini, and T. B. Strom. 1999. CTLA4 signals are required to optimally induce allograft tolerance with combined DST and anti-CD154 mAb treatment. J. Immunol. 162:4983.
12. Markees, T. G., N. E. Phillips, E. J. Gordon, R. J. Noelle, J. P. Mordes, D. L. Greiner, and A. A. Rossini. 1999. Prolonged skin allograft survival in mice treated with Flt3-ligand-induced dendritic cells and anti-CD154 monoclonal antibody. Transplant. Proc. 31:884.
13. Markees, T. G., N. E. Phillips, E. J. Gordon, R. J. Noelle, J. P. Mordes, D. L. Greiner, and A. A. Rossini. 1998. Improved skin allograft tolerance induced by treatment with donor splenocytes and an extended course of anti-CD154 monoclonal antibody. Transplant. Proc. 30:2444.
14. + T cells, interferon-γ, and CTLA4. J. Clin. Invest. 101:2446.
15. Markees, T. G., N. E. Phillips, R. J. Noelle, L. D. Shultz, J. P. Mordes, D. L. Greiner, and A. A. Rossini. 1997. Prolonged survival of mouse skin allografts in recipients treated with donor splenocytes and antibody to CD40 ligand. Transplantation 64:329.
16. Parker, D. C., D. L. Greiner, N. E. Phillips, M. C. Appel, A. W. Steele, F. H. Durie, R. J. Noelle, J. P. Mordes, and A. A. Rossini. 1995. Survival of mouse pancreatic islet allografts in recipients treated with allogeneic small lymphocytes and antibody to CD40 ligand. Proc. Natl. Acad. Sci. USA 92:9560.
17. Rossini, A. A., D. C. Parker, N. E. Phillips, F. H. Durie, R. J. Noelle, J. P. Mordes, and D. L. Greiner. 1996. Induction of immunological tolerance to islet grafts. Cell Transplant. 5:49.
18. Schoenberger, S. P., R. E. M. Toes, E. I. H. Van der Voort, R. Offringa, and C. J. M. Melief. 1998. T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions. Nature 393:480.
19. + T lymphocytes generates a costimulatory signal that up-regulates IL-4 synthesis. J. Immunol. 156:3133.
20. + cytotoxic T lymphocytes (CTL) but are not required for the maintenance of CTL memory following virus infection. J. Virol. 72:7440.
21. Tafuri, A., J. Alferink, P. Möller, G. J. Hämmerling, and B. Arnold. 1995. T cell awareness of paternal alloantigens during pregnancy. Science 270:630.
22. Kearney, E. R., K. A. Pape, D. Y. Loh, and M. K. Jenkins. 1994. Visualization of peptide-specific T cell immunity and peripheral tolerance induction in vivo. Immunity 1:327.
23. Chen, S. Z., and G. A. Evans. 1990. A simple screening method for transgenic mice using the polymerase chain reaction. BioTechniques 8:32.
24. Hue, I., J. Trucy, C. McCoy, D. Couez, B. Malissen, and M. Malissen. 1990. A novel type of aberrant T cell receptor α-chain gene rearrangement: implications for allelic exclusion and the V-J recombination process. J. Immunol. 144:4410.
25. Foy, T. M., D. M. Shepherd, F. H. Durie, A. Aruffo, J. A. Ledbetter, and R. J. Noelle. 1993. In vivo CD40-gp39 interactions are essential for thymusdependent humoral immunity. II. Prolonged suppression of the humoral immune response by an antibody to the ligand for CD40, gp39. J. Exp. Med. 178:1567.
26. Reeves, J. P., and P. A. Reeves. 1994. Care and handling of laboratory animals. Survival surgery: removal of the spleen or thymus. In Current Protocols in Immunology. J. E. Coligan, A. M. Kruisbeek, D. H. Margulies, E. M. Shevach, and W. Strober, eds. Wiley, New York, p. 1.10.1.
27. Kruisbeek, A. M. 1994. In vivo depletion of CD4- and CD8-specific T cells. In Current Protocols in Immunology. J. E. Coligan, A. M. Kruisbeek, D. H. Margulies, E. M. Shevach, and W. Strober, eds. Wiley, New York, p. 4.1.1.
28. Cook, M. J. 1983. Anatomy. In The Mouse in Biomedical Research. H. L. Foster, J. D. Small, and J. G. Fox, eds. Academic, New York, p. 101.
29. Zadeh, H. H., D. L. Greiner, D. Y. Wu, F. Tausche, and I. Goldschneider, 1996. Abnormalities in the export and fate of recent thymic emigrants in diabetes-prone BB/W rats. Autoimmunity 24:35.
30. + T cells in vivo is dependent on CD28 costimulation and inhibited by CTLA-4. J. Immunol. 155:1032.
31. Kaplan, E. L., and P. Meier. 1958. Nonparametric estimation from incomplete observations. J. Am. Stat. Assoc. 53:457.
32. Nie, N. H., C. H. Hull, J. G. Jenkins, K. Steinbrenner, and D. H. Bent. 1975. Statistical Package for the Social Sciences. McGraw-Hill, New York, p. 1.
33. Glantz, S. A. 1981. Primer of Biostatistics. McGraw-Hill, New York, p. 352.
34. Croft, M., and C. Dubey. 1997. Accessory molecule and costimulation requirements for CD4 T cell response. CRC Crit. Rev. Immunol. 17:89.
35. Lanzavecchia, A., G. Iezzi, and A. Viola. 1999. From TCR engagement to T cell activation: a kinetic view of T cell behavior. Cell 96:1.
36. Mackey, M. F., R. J. Barth, Jr., and R. J. Noelle. 1998. The role of CD40/CD154 interactions in the priming, differentiation, and effector function of helper and cytotoxic T cells. J. Leukocyte Biol. 63:418.
37. Van Parijs, L., A. Ibraghimov, and A. K. Abbas. 1996. The roles of costimulation and Fas in T cell apoptosis and peripheral tolerance. Immunity 4:321.
38. L. Immunity 3:87.
39. Noel, P. J., L. H. Boise, J. M. Green, and C. B. Thompson. 1996. CD28 costimulation prevents cell death during primary T cell activation. J. Immunol. 157:636.
40. Poudrier, J., D. Van Essen, S. Morales-Alcelay, T. Leanderson, S. Bergthorsdottir, and D. Gray. 1998. CD40 ligand signals optimize T helper cell cytokine production: role in Th2 development and induction of germinal centers. Eur. J. Immunol. 28:3371.
41. Brown, M. G., A. A. Scalzo, K. Matsumoto, and W. M. Yokoyama. 1997. The natural killer gene complex: A genetic basis for understanding natural killer cell function and innate immunity. Immunol. Rev. 155:53.
42. + T-cell responses. Curr. Biol. 4:499.
43. Webb, S., C. Morris, and J. Sprent. 1990. Extrathymic tolerance of mature T cells: clonal elimination as a consequence of immunity. Cell 63:1249.
44. Waanders, G. A., A. N. Shakhov, W. Held, O. Karapetian, H. Acha-Orbea, and H. R. MacDonald. 1993. Peripheral T cell activation and deletion induced by transfer of lymphocyte subsets expressing endogenous or exogenous mouse mammary tumor virus. J. Exp. Med. 177:1359.
45. Woodland, D. L., and M. A. Blackman. 1992. Retroviral super-antigens and T cells. Int. Rev. Immunol. 8:311.
46. Acha-Orbea, H., A. N. Shakhov, L. Scarpellino, E. Kolb, V. Muller, A. Vessaz-Shaw, R. Fuchs, K. Blochlinger, P. Rollini, J. Billotte, et al. 1991. Clonal deletion of Vβ14-bearing T cells in mice transgenic for mammary tumour virus. Nature 350:207.
47. Choi, Y., J. W. Kappler, and P. Marrack. 1991. A superantigen encoded in the open reading frame of the 3′ long terminal repeat of mouse mammary tumour virus. Nature 350:203.
48. + T cells. J. Exp. Med. 185:405.
49. Wekerle, T., M. H. Sayegh, J. Hill, Y. Zhao, A. Chandraker, K. G. Swenson, G. Zhao, and M. Sykes. 1998. Extrathymic T cell deletion and allogeneic stem cell engraftment induced with costimulatory blockade is followed by central T cell tolerance. J. Exp. Med. 187:2037.
50. Huang, L., and I. N. Crispe. 1993. Superantigen-driven peripheral deletion of T cells. Apoptosis occurs in cells that have lost the α/β T cell receptor. J. Immunol. 151:1844.
51. +T cells in mice tolerant to Staphylococcus aureus enterotoxin B. Nature 349:245.
52. Rocha, B., and H. Von Boehmer. 1991. Peripheral selection of the T cell repertoire. Science 251:1225.
53. b in the liver. Eur. J. Immunol. 25:1932.
54. Zhang, L. 1996. The fate of adoptively transferred antigen-specific T cells in vivo. Eur. J. Immunol. 26:2208.
55. + T cell deletion induced by cross-presentation of self-antigens and favors autoimmunity. J. Exp. Med. 186: 2057.
56. Bennett, S. R. M., F. R. Carbone, F. Karamalis, R. A. Flavell, J. F. A. P. Miller, and W. R. Heath. 1998. Help for cytotoxic-T-cell responses is mediated by CD40 signalling. Nature 393:478.
57. Judge, T. A., Z. H. Wu, X. G. Zheng, A. H. Sharpe, M. H. Sayegh, and L. A. Turka. 1999. The role of CD80, CD86, and CTLA4 in alloimmune responses and the induction of long-term allograft survival. J. Immunol. 162:1947.
58. Tivol, E. A., S. D. Boyd, S. McKeon, F. Borriello, P. Nickerson, T. B. Strom, and A. H. Sharpe. 1997. CTLA4Ig prevents lymphoproliferation and fatal multiorgan tissue destruction in CTLA-4-deficient mice. J. Immunol. 158:5091.
59. Perez, V. L., L. Van Parijs, A. Biuckians, X. X. Zheng, T. B. Strom, and A. K. Abbas. 1997. Induction of peripheral T cell tolerance in vivo requires CTLA-4 engagement. Immunity 6:411.
60. Allison, J. P., C. Chambers, A. Hurwitz, T. Sullivan, B. Boitel, S. Fournier, M. Brunner, and M. Krummel. 1998. A role for CTLA-4-mediated inhibitory signals in peripheral T cell tolerance? Novartis Found. Symp. 215:92.
61. Sperling, A. I., and J. A. Bluestone. 1996. The complexities of T-cell co-stimulation: CD28 and beyond. Immunol. Rev. 153:155.
62. Sayegh, M. H., X. G. Zheng, C. Magee, W. W. Hancock, and L. A. Turka. 1997. Donor antigen is necessary for the prevention of chronic rejection in CTLA4Ig-treated murine cardiac allograft recipients. Transplantation 64:1646.
63. Larsen, C. P., E. T. Elwood, D. Z. Alexander, S. C. Ritchie, R. Hendrix, C. Tucker-Burden, H. R. Cho, A. Aruffo, D. Hollenbaugh, P. S. Linsley, et al. 1996. Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways. Nature 381:434.
64. Kirk, A. D., D. M. Harlan, N. N. Armstrong, T. A. Davis, Y. C. Dong, G. S. Gray, X. N. Hong, D. Thomas, J. H. Fechner, Jr., and S. J. Knechtle. 1997. CTLA4-Ig and anti-CD40 ligand prevent renal allograft rejection in primates. Proc. Natl. Acad. Sci. USA 94:8789.
65. Lombardi, G., S. Sidhu, R. Batchelor, and R. Lechler. 1994. Anergic T cells as suppressor cells in vitro. Science 264:1587.
66. Frasca, L., P. Carmichael, R. Lechler, and G. Lombardi. 1997. Anergic T cells effect linked suppression. Eur. J. Immunol. 27:3191.